arrow
N

Norbert Stefan

University Hospital Tübingen
H指数:95
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Heart–liver co-management in MASLD: expert perspectives and recommendations from a multidisciplinary cardiometabolic framework

心脏-肝脏共管在MASLD中的专家观点和多学科心血管代谢框架建议

2026-09-090
PRE
Type 2 diabetes prevention across the life course

生命历程中的2型糖尿病预防

2026-08-100
PRE
Refining visceral adipose tissue quantification: Influence of sex, age, and BMI on single slice estimation in 3D MRI of the German National Cohort

改进内脏脂肪组织定量:性别、年龄和BMI对德国国家队列3D MRI单层面估计的影响

2026-02-010
OAAI
Superiority of 1 h plasma glucose vs fasting plasma glucose, 2 h plasma glucose and HbA1c for the diagnosis of type 2 diabetes

1小时血浆葡萄糖与空腹血浆葡萄糖、2小时血浆葡萄糖和HbA1c相比,在2型糖尿病诊断中的优越性。

2025-12-120
OAAI
Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study

糖尿病前期缓解与心血管发病率和死亡率:来自糖尿病预防项目结局研究和大庆糖尿病预防结局研究的后续分析

2025-12-120
OA
Lifestyle intervention is more effective in high 1-hour post-load glucose than in prediabetes for restoring β-cell function, reducing ectopic fat, and preventing type 2 diabetes

生活方式干预在恢复β细胞功能、减少异位脂肪以及预防2型糖尿病方面,对高1小时负荷后血糖人群的效果优于对糖尿病前期人群。

2025-11-030
OAAI
Prevention of type 2 diabetes through prediabetes remission without weight loss

通过糖尿病前期缓解而非体重减轻来预防2型糖尿病

2025-09-290
OAAI
Sodium-Glucose Cotransporter 2 Inhibitor Use and Risk of Liver-Related Events in Patients With Type 2 Diabetes: A Meta-analysis of Observational Cohort Studies

Sodium-Glucose Cotransporter 2 Inhibitor使用与2型糖尿病患者肝脏相关事件风险:一项基于观察性队列研究的荟萃分析

2025-05-200
PRE
Subphenotype-Dependent Benefits of Bariatric Surgery for Individuals at Risk for Type 2 Diabetes

肥胖手术对2型糖尿病风险个体的亚表型依赖性益处

2025-04-110
PRE